CRGX Live signaler | Maksimer profitt med Getagraph.com

KJøP 120030 min ago

@ $21.56

Utstedt: 14 feb 2024 @ 20:23

Avkastning: -6.10%

Forrige signal: feb 14 - 15:30

Forrige signal: Selg

Avkastning: -1.98 %

Live Chart Being Loaded With Signals

Commentary (7 mai 2024 @ 22:00):

Stats
Dagens volum	71 623.00
Gjennomsnittsvolum	313 354
Markedsverdi	796.82M
EPS	$0 ( 2024-03-27 )
Neste inntjeningsdato	( $-1.050 ) 2024-06-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0580 (0.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-12	Rtw Investments, Lp	Sell	1 842 499	Common stock, par value $0.001 per share ("Common Stock")
2023-11-14	Rtw Investments, Lp	Buy	0	Common stock, par value $0.001 per share
2023-11-14	Perceptive Advisors Llc	Buy	333 333	Common Stock
2023-11-14	Perceptive Advisors Llc	Buy	2 579 502	Common Stock
2023-11-14	Perceptive Advisors Llc	Buy	333 333	Common Stock

INSIDER POWER
-17.48
Last 10 transactions
Buy: 3 296 168 \| Sell: 4 503 291

Volum Korrelasjon

Lang: -0.17 (neutral)

Kort: -0.63 (weak negative)

Signal:(44.282) Neutral

CARGO Therapeutics, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

CARGO Therapeutics, Inc. Korrelasjon - Valuta/Råvare

-0.16
( neutral )

-0.35
( neutral )

0.00
( neutral )

-0.17
( neutral )

-0.11
( neutral )

0.14
( neutral )

CARGO Therapeutics, Inc. Økonomi

Annual	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$0

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

CARGO Therapeutics, Inc.

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.